Kazia Therapeutics Limited
KZIA
$13.25
$3.1931.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.28M | -3.21M | -3.41M | -3.50M | -5.92M |
| Total Depreciation and Amortization | -200.00 | -200.00 | 304.50K | 313.10K | 307.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.35M | 2.30M | 708.90K | 728.90K | 1.52M |
| Change in Net Operating Assets | -618.50K | -605.70K | -350.90K | -360.80K | 3.02M |
| Cash from Operations | -1.56M | -1.52M | -2.74M | -2.82M | -1.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -300.00 |
| Total Debt Repaid | -- | -- | -- | -- | 400.00 |
| Issuance of Common Stock | 1.96M | 1.96M | 4.87M | 4.87M | 644.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.16M | 1.16M | -- | -- | -27.90K |
| Cash from Financing | 2.00M | 1.96M | 3.17M | 3.26M | 406.00K |
| Foreign Exchange rate Adjustments | -33.10K | -32.40K | 28.50K | 29.30K | 35.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 410.40K | 401.80K | 458.40K | 471.30K | -627.80K |